17β-hydroxysteroid dehydrogenase in common epithelial ovarian tumors

Modern Pathology

Volumn 9, Issue 4, 1996, Pages 386-391

  Sasano, Hironobu ^a   Suzuki, Takashi ^b   Niikura, Hitoshi ^b   Kaga, Keiko ^b   Sato, Shinji ^b   Yajima, Akira ^b   Rainey, William E ^b   Nagura, Hiroshi ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

17 hydroxysteroid dehydrogenase; Carcinoma; Estrogens; Immunohistochemistry; Ovary

Indexed keywords

ESTRADIOL; ESTRONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CONTROLLED STUDY; CYSTADENOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL;

17-HYDROXYSTEROID DEHYDROGENASES; ADENOCARCINOMA; CYSTADENOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 0029998817     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rao BR, Slotman BJ: Endocrine factors in common epithelial ovarian cancer. Endocr Rev 12:14, 1991
2. Rose PG, Reale FR, Longcope C, Hunter RE: Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer. Obstet Gynecol 76:258, 1990
3. Slotman BJ, Nauta JJ, Rao BR: Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator. Cancer 66:740, 1990
4. Stadel BV: The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 123:772, 1975
5. Cramer DW, Welch WR: Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717, 1983
6. MacDonald PC, Grodin JM, Edman CD, Vellios F, Siiteri PK: Origin of estrogen in a postmenopausal woman with a non-endocrine tumor of the ovary and endometrial hyperplasia. Obstet Gynecol 47:644, 1976
7. Pittaway DE, Andersen RN, Givens JR: Characterization of human ovarian oestradiol-17β oxidoreductase activity. Acta Endocrinol (Copenh) 85:624, 1977
8. Williamson DG: The biochemistry of the 17β-hydroxysteroid dehydrogenases. J Steroid Biochem 1:83, 1979
9. Casey ML, MacDonald PC, Andersson S: 17β-hydroxysteroid dehydrogenase type 2: Chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 94:2135, 1994
10. Martel C, Melner MH, Gagne D, Simard J, Labrie F: Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/δ5-δ4 isomerase (3β-HSD), 17β-HSD 5α-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol 104:103, 1994
11. Pautanen M, Isomaa V, Lehto VP, Vihko R: Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 51:386, 1992
12. Maentausta O, Boman K, Isomaa V, et al.: Immunohistochemical study of the human 17β-hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma. Cancer 70:1551, 1992
13. Sawetawan C, Milewich L, Word RA, Carr BR, Rainey WE: Compartmentalization of type 1 17β-hydroxysteroid oxidoreductase in the human ovary. Mol Cellular Endocrinol 99:161, 1994
14. Milewich L, Carr BR, Frenkel RA, et al.: 17β-hydroxysteroid oxidoreductases of human fetal and adult tissues: Immunological cross-reactivity with an anti-human placental cytosolic 17β-hydroxysteroid oxidoreductase antibody. Fertil Steril 59:143, 1993
15. Maentausta O, Sormunen R, Isomaa V, et al.: Immunohistochemical localization of 17β-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle. Lab Invest 65:582, 1991
16. Wu L, Einstein M, Geissler WM, et al.: Expression, cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 268:12964, 1993
17. Maentausta O, Peltoketo H, Isomaa V, Jouppila P, Vihko R: Immunological measurement of human 17β-hydroxysteroid dehydrogenase. J Steroid Biochem 36:673, 1990
18. Tseng L, Gurpide E: Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97:825, 1975
19. Ghersevich S, Poutanen M, Tapanainen J, Vihko R: Hormonal regulation of rat 17β-hydroxysteroid dehydrogenase type 1 in culture rat granulosa cells: Effects of recombinant follicle-stimulating hormone, estrogens, androgens, and epidermal growth factor. Endocrinology 135:1963, 1994
20. Ghersevich S, Nodilainen, Poutanen M, et al.: Rat 17β-hydroxysteroid dehydrogenase type 1: Primary structure and regulation of enzyme expression in rat ovary by diethylstilbestrol and gonadotropins in vivo. Endocrinology 135:1477, 1994
21. Reed MJ, Rea D, Duncan LJ, Parker MG: Regulation of estradiol 17β-hydroxysteroid dehydrogenase gene expression and activity by retinoid acid in T-47D breast cancer cells. Endocrinology 135:4, 1994
22. Poutanen M, Moncharmont B, Vihko R: 17β-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: Regulation of expression by a progestin. Cancer Res 45:897, 1992
23. Ritvos O, Voutilainen R: Regulation of aromastase cytochrome P-450 and 17β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels in choriocarcinoma cells. Endocrinology 130:61, 1992
24. Tremblay Y, Beaudoin C: Regulation of 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3′,5′-monophosphate and phorbol myristate acetate in human choriocarcinoma cells. Mol Endocrinol 7:355, 1993
25. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25:530, 1994
26. Watanabe K, Sasano H, Harada N, et al.: Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol 146:491, 1995